Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Type
ArticleAuthor/s
Pfaar, O.Klimek, L.
Jutel, M.
Akdis, C.
Bousquet, J.
Akdis, M.
Bachert, C.
Agache, I.
Ansotegui, I.
Bedbrook, A.
Bosnic-Anticevich, S.
Canonica, G.W.
Chivato, T.
Cruz, A.A.
Czarlewski, W.
Del Giacco, S.
Du, H.
Fonseca, J.A.
Gao, Y.
Haahtela, T.
Hoffmann-Sommergruber, K.
Ivancevich, J.C.
Khaltaev, N.
Knol, E.F.
Kuna, P.
Larenas-Linnemann, D.
Melen, E.
Mullol, J.
Naclerio, R.
Ohta, K.
Okamoto, Y.
O'Mahony, L.
Onorato, G.L.
Papadopoulos, N.G.
Pawankar, R.
Samolinski, B.
Schwarze, J.
Toppila-Salmi, S.
Shamji, M.H.
Teresa Ventura, M.
Valiulis, A.
Yorgancioglu, A.
Matricardi, P.
Zuberbier, T.
Date
2020Licence
OtherFaculty/School
Faculty of Medicine and Health, Sydney Medical SchoolShare